Dashboard
Manage Tickers

OPTOpthea Ltd

Nasdaq opthea.com


$ 3.05 $ 0.04 (1.31 %)    

Tuesday, 10-Sep-2024 14:09:29 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.86 $ 0.00 (0 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 3.1
$ 3.05 x 100
-- x --
-- - --
$ 1.60 - $ 4.40
9,880
na
427.42M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

opthea-taps-daniel-geffken-of--danforth-advisors-as-interim-cfo-effective-september-9-taking-over-from-peter-lang
Opthea Taps Daniel Geffken Of Danforth Ad...
09/05/2024 10:06:41

Opthea Limited (NASDAQ:OPT, "Opthea", the "Company")))), a clinical-stage biopharmaceutical Company developing ...

hc-wainwright--co-maintains-buy-on-opthea-lowers-price-target-to-12
HC Wainwright & Co. Maintains Buy on Opthe...
09/03/2024 14:56:49

HC Wainwright & Co. analyst Matthew Caufield maintains Opthea (NASDAQ:OPT) with a Buy and lowers the price target from $...

opthea-fy-adjusted-eps-027-up-from-030-yoy-sales-12467k-up-from-10841k-yoy
Opthea FY Adjusted EPS $(0.27) Up From $(0...
08/30/2024 11:36:48

reported-sunday-opthea-successfully-completes-a559m-retail-entitlement-offer-marking-the-final-stage-of-a2273m-capital-raising
Reported Sunday, Opthea Successfully Compl...
07/15/2024 06:07:52

New Shares under the Retail Entitlement Offer and New Options under the Placement and Entitlement Offer expected to commence ...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/14/2024 12:06:22

trading-halt-halt-status-updated-at-70000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:00:...
06/14/2024 11:00:04

reported-earlier-opthea-secures-funding-path-with-a227m-capital-raise-aimed-at-accelerating-wet-amd-therapeutic-trials
Reported Earlier, Opthea Secures Funding P...
06/12/2024 06:50:19

trading-halt-halted-at-71048-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:10:48 p.m. ET - ...
06/06/2024 23:10:52

optheas-pivotal-phase-3-trials-for-sozinibercept-in-wet-amd-completes-enrollment-topline-results-anticipated-mid-2025
Opthea's Pivotal Phase 3 Trials For Sozini...
05/28/2024 12:17:39

Phase 3 program enrolled 1,984 patients across COAST and ShORe trials Trials designed to replicate superiority in visual out...

Core News & Articles
Watching Protara Therapeutics, Opthea Ltd....
05/09/2024 14:24:33

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-surge-over-400-says-oppenheimer/

opthea-reports-1571m-in-cash-and-cash-equivalents-as-of-december-31-2023-provides-business-updates
Opthea Reports $157.1M In Cash And Cash Eq...
02/28/2024 22:58:59

opthea-has-completed-enrollment-in-coast-phase-3-trial-of-sozinibercept-plus-aflibercept-for-wet-age-related-macular-degeneration-enrollment-in-shore-study-is-expected-to-be-completed-in-q2-2024-topline-data-from-both-trials-are-expected-by-mid-2025
Opthea Has Completed Enrollment In COAST P...
02/14/2024 11:17:17

why-netflix-shares-are-trading-higher-by-10-here-are-20-stocks-moving-premarket
Why Netflix Shares Are Trading Higher By 1...
01/24/2024 13:14:23

Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-e...

why-is-retinal-diseases-focused-opthea-stock-trading-higher-today
Why Is Retinal Diseases-Focused Opthea Sto...
12/27/2023 15:03:56

Opthea Limited (NASDAQ: OPT) on Wednesday said it expects to receive the remaining $35 million committed funds under the Develo...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/27/2023 13:07:19

opthea-expects-to-receive-the-remaining-35m-committed-funds-under-development-funding-agreement-with-carlyle-and-abingworth
Opthea Expects To Receive The Remaining $3...
12/27/2023 11:02:05

This financing is non-dilutive to shareholders, with no equity issued to Carlyle, Abingworth or the new co-investor

opthea-has-received-an-a88m-59m-rd-tax-credit-from-the-australian-taxation-office
Opthea Has Received An A$8.8M ($5.9M) R&D ...
12/19/2023 11:02:52

opthea-limited-appoints-frederic-guerard-as-chief-executive-officer-effective-immediately-guerard-to-replace-megan-baldwin-who-will-transition-to-founder-and-chief-innovation-officer-post-company-also-appoints-peter-lang-as-chief-financial-officer
Opthea Limited Appoints Frederic Guerard A...
10/27/2023 09:39:00

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

  During the session on Thursday, 461 stocks hit new 52-week lows.

oppenheimer-maintains-outperform-on-opthea-lowers-price-target-to-16
Oppenheimer Maintains Outperform on Opthea...
09/13/2023 16:25:04

Oppenheimer analyst Hartaj Singh maintains Opthea (NASDAQ:OPT) with a Outperform and lowers the price target from $31 to $16.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION